T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Penumbra
PEN
$12.9B
| $344M | 0.03% |
1,255,196
-34,217
| -3% | -$9.34M |
|
427
Bilibili
BILI
$7.14B
| $341M | 0.03% |
2,799,901
+2,794,256
| +49,500% | +$303M |
|
|
OCDX
428
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $338M | 0.03% |
15,796,863
-74,725
| -0.5% | -$1.52M |
|
429
Air Products & Chemicals
APD
$68B
| $338M | 0.03% |
1,174,069
-84,164
| -7% | -$24.7M |
|
430
Rockwell Automation
ROK
$49.5B
| $337M | 0.03% |
1,177,714
-15,304
| -1% | -$4.13M |
|
|
CTEV
431
Claritev Corp
CTEV
$716M
| $336M | 0.03% |
883,079
+28,284
| +3% | +$8.76M |
|
432
Home BancShares
HOMB
$6.27B
| $335M | 0.03% |
13,590,612
-1,773,026
| -12% | -$47.9M |
|
|
PXD
433
DELISTED
Pioneer Natural Resource Co.
PXD
| $332M | 0.03% |
2,042,535
-252,632
| -11% | -$39.7M |
|
434
PagerDuty
PD
$932M
| $332M | 0.03% |
7,786,162
-3,826,403
| -33% | -$155M |
|
|
BNY
435
Bank of New York Mellon
BNY
$110B
| $331M | 0.03% |
6,465,843
+239,336
| +4% | +$12M |
|
436
Novanta
NOVT
$6.33B
| $327M | 0.03% |
2,427,403
-38,142
| -2% | -$5.13M |
|
437
Vistra
VST
$49.1B
| $327M | 0.03% |
17,632,821
+9,763,243
| +124% | +$169M |
|
|
APLS
438
DELISTED
Apellis Pharmaceuticals
APLS
| $327M | 0.03% |
5,170,494
+1,528,345
| +42% | +$78.9M |
|
439
East-West Bancorp
EWBC
$18.6B
| $324M | 0.03% |
4,522,950
+76,000
| +2% | +$5.65M |
|
440
Canadian Natural Resources
CNQ
$98.1B
| $322M | 0.03% |
18,144,787
-1,645,562
| -8% | -$27.1M |
|
441
Envista
NVST
$4.51B
| $321M | 0.03% |
7,439,880
-11,861,833
| -61% | -$515M |
|
442
Apollo Global Management
APO
$84.8B
| $320M | 0.03% |
5,150,318
+4,193,011
| +438% | +$233M |
|
443
Howmet Aerospace
HWM
$113B
| $320M | 0.03% |
9,281,878
+651,534
| +8% | +$21.7M |
|
|
JBTM
444
JBT Marel
JBTM
$6.1B
| $319M | 0.03% |
2,234,470
-14,270
| -0.6% | -$1.99M |
|
445
Rollins
ROL
$17.4B
| $318M | 0.03% |
9,298,434
+1,530,385
| +20% | +$53.4M |
|
446
Live Oak Bancshares
LOB
$2.01B
| $315M | 0.03% |
5,338,258
-33,522
| -0.6% | -$2.1M |
|
447
Five Below
FIVE
$13.4B
| $315M | 0.03% |
1,628,404
+8,427
| +0.5% | +$1.61M |
|
448
Lockheed Martin
LMT
$138B
| $311M | 0.03% |
821,787
-7,536
| -0.9% | -$2.9M |
|
449
Manhattan Associates
MANH
$11.7B
| $310M | 0.03% |
2,143,407
+580,286
| +37% | +$77.3M |
|
|
MRTX
450
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $310M | 0.03% |
1,921,779
+389,279
| +25% | +$62.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.